Reaction
B-Cell Small Lymphocytic Lymphoma reporting signals
As of the last recalculation, B-Cell Small Lymphocytic Lymphoma appears in 224 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is ACALABRUTINIB (PRR 63.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Acalabrutinib | 8 | 63.6 | 63.6 |
| Bendamustine Hcl | 7 | 43.3 | 43.3 |
| Venetoclax | 25 | 42.3 | 42.4 |
| Ibrutinib | 31 | 41.2 | 41.2 |